We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current VOR market cap is 61.81M. The company's latest EPS is USD -1.7163 and P/E is -0.51.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -35.32M | -28.12M | -32.33M | -29.04M | -28.51M |
| Net Income | -33.19M | -26.26M | -30.8M | -27.84M | -27.56M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10.42M | -43.37M | -69.02M | -93.42M | -126.04M |
| Net Income | -12.61M | -49.26M | -70.13M | -92.09M | -117.86M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 223.02M | 198.13M | 167.03M | 141.59M | 115.99M |
| Total Liabilities | 48.24M | 47.4M | 44M | 43.51M | 43.04M |
| Total Equity | 174.78M | 150.72M | 123.04M | 98.08M | 72.96M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 9.83M | 75.91M | 242.59M | 299.37M | 198.13M |
| Total Liabilities | 2.19M | 27.64M | 26.33M | 48.76M | 47.4M |
| Total Equity | -17.43M | -59.07M | 216.26M | 250.61M | 150.72M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -76.27M | -100.29M | -30.47M | -52.31M | -75.6M |
| Investing | 60.67M | 71.01M | 43.97M | 96.96M | 96.93M |
| Financing | 2.91M | 2.94M | 96k | 65k | 106k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.86M | -36.29M | -69.14M | -85.14M | -100.29M |
| Investing | -748k | -4.16M | -91.65M | -94.09M | 71.01M |
| Financing | 17.7M | 82.53M | 232.91M | 117.14M | 2.94M |
| Market Cap | 61.81M |
| Price to Earnings Ratio | -0.51 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.9 |
| Price to Book Ratio | 0.4 |
| Dividend Yield | - |
| Shares Outstanding | 68.67M |
| Average Volume (1 week) | 328.01k |
| Average Volume (1 Month) | 580.81k |
| 52 Week Change | -62.81% |
| 52 Week High | 3.1399 |
| 52 Week Low | 0.6354 |
| Spread (Intraday) | 0.04 (4.44%) |
| Company Name | Vor Biopharma Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.vorbio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
